Indication
Polycystic Ovary Syndrome
79 clinical trials
79 products
4 drugs
Product
UC-MSCsProduct
SecretomesClinical trial
Potential Use of Umbilical Cord Mesenchymal Stem Cells and Secretoms for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.Status: Recruiting, Estimated PCD: 2023-12-01
Product
ControlProduct
TildacerfontClinical trial
A Randomized, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of Tildacerfont in Adult Subjects With Polycystic Ovary Syndrome (PCOS) and Elevated Adrenal AndrogensStatus: Completed, Estimated PCD: 2023-08-03
Product
PlaceboClinical trial
Analysis of Gut Microbiome in Thai Women With Polycystic Ovary Syndrome and the Synbiotics Effect on Reproductive and Cardiovascular Risk: A Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Drug
placeboClinical trial
A Phase II, Randomised, Multi-centric, Multi-national Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) for Adolescent Girls and Young Adult Women (AYAs) With Polycystic Ovary Syndrome (PCOS)Status: Recruiting, Estimated PCD: 2025-04-01
Product
PioglitazoneProduct
SpironolactoneDrug
MetforminClinical trial
Influence of Hyperandrogenemia on the Sleep-associated Slowing of Follicular LH Frequency in Adult Polycystic Ovary SyndromeStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Product
FlutamideClinical trial
Mechanisms of Hypertension in Women With Polycystic Ovary SyndromeStatus: Terminated, Estimated PCD: 2022-06-30
Product
GnRH antagonistClinical trial
Acupuncture or Metformin for Insulin Resistance in Women With Polycystic Ovary Syndrome: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Ability of Androgen-receptor Blockade to Normalize Progesterone-induced Augmentation of Gonadotropin Secretion in PCOS (CRM010)Status: Recruiting, Estimated PCD: 2025-10-01
Product
Micronized progesteroneProduct
EstradiolClinical trial
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary SyndromeStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
The Clinical Efficacy and Mechanism of SGLT2 Inhibitors Treating Polycystic Ovary Syndrome by Modulating the Nod-like Receptor Protein 3 InflammasomeStatus: Recruiting, Estimated PCD: 2024-12-15
Product
SGLT2 inhibitorsProduct
metforminClinical trial
Probiotic Dietary Intervention in Polycystic Ovary Syndrome (PCOS) - A Randomized Controlled TrialStatus: Completed, Estimated PCD: 2023-10-16
Clinical trial
Dampening the Reproductive Axis With Continuous KisspeptinStatus: Recruiting, Estimated PCD: 2023-12-31
Product
KisspeptinProduct
GnRHClinical trial
Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess (CBS005)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Ovarian Contribution to Androgen Production in Adolescent GirlsStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Product
DexamethasoneProduct
rhCGClinical trial
Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome Combined With Non-Alcoholic Fatty Liver Disease: A Single-center, Open-labeled Prospective Randomized ControlledStatus: Not yet recruiting, Estimated PCD: 2025-04-30
Product
CanagliflozinProduct
MetforminClinical trial
Effectiveness of the Combination Liraglutide and Metformin on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With Polycystic Ovarian Syndrome, Obesity and InfertilityStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Product
Liraglutide + MetforminClinical trial
Effect Polyunsaturated Fatty Acids or Magnesium in Metabolic, Hormonal, and Inflammatory Profile in Obese Women With Polycystic Ovary Syndrome. A Randomized Clinical TrialStatus: , Estimated PCD: 2020-08-01
Clinical trial
Prediction of Immune Status on the Efficacy of Metformin in the Treatment of Polycystic Ovary SyndromeStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
The Combination of Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome PatientsStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Product
MyoinositolProduct
ChromiumProduct
l-arginineClinical trial
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOSStatus: Recruiting, Estimated PCD: 2026-04-01
Product
ACTHClinical trial
Pilot Trial of Bicalutamide Versus Placebo in Reproductive-Aged Women With Nonalcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovary Syndrome (PCOS)Status: Recruiting, Estimated PCD: 2028-08-01
Product
BicalutamideClinical trial
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Polycystic Ovary SyndromeStatus: Recruiting, Estimated PCD: 2027-11-16
Product
AlloRxClinical trial
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone (LH) Pulse Frequency in Pubertal Girls With Hyperandrogenism? (CBS010)Status: Recruiting, Estimated PCD: 2025-10-01
Clinical trial
Suppression of Daytime and Nighttime LH Frequency by Progesterone in Early Pubertal Girls With and Without Hyperandrogenemia (JCM024)Status: Recruiting, Estimated PCD: 2024-12-01
Product
ProgesteroneClinical trial
Study to Evaluate if Androgen-receptor Blockade (Spironolactone) Improves Progesterone-suppression of Wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With HyperandrogenismStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Effect of GnRH Agonist (Long Protocol) vs GnRH Antagonist (Flexible Protocol) on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSIStatus: Completed, Estimated PCD: 2022-02-15
Product
TriptorelinProduct
CetrorelixProduct
Recombinant FSHProduct
Human Chorionic GonadotropinClinical trial
Chiglitazar Versus Metformin for Insulin Resistance in Non-obese Patients With Polycystic Ovary SyndromeStatus: , Estimated PCD: 2026-04-01
Clinical trial
The Change in Microbiome Following Treatment of Women With Polycystic OvariesStatus: Recruiting, Estimated PCD: 2026-03-30
Product
Oral contraceptive pillsClinical trial
Independent and Additive Effects Of Micronutrients With Metformin In Patients With PCOS:A Double Blind Randomized Placebo Controlled TrialStatus: Completed, Estimated PCD: 2023-12-30
Product
Acetyl-L-CarnitinClinical trial
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With AnovulationStatus: Active (not recruiting), Estimated PCD: 2024-03-01
Product
LetrozoleProduct
Clomiphene CitrateClinical trial
Treating PCOS With Semaglutide vs Active Lifestyle InterventionStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Product
SemaglutideClinical trial
Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Normal and Hyperandrogenemic Adolescent Girls (JCM010)Status: Active (not recruiting), Estimated PCD: 2025-08-01
Product
estraceClinical trial
Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation (JCM022)Status: Active (not recruiting), Estimated PCD: 2024-08-27
Product
CortrosynClinical trial
Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome During Induction of Ovulation With Clomiphene CitrateStatus: Recruiting, Estimated PCD: 2027-09-12
Clinical trial
Randomized Clinical Trial to Evaluate The Effect of Metformin-GLP-1 Receptor Agonist Versus Oral Contraceptive (OC) Therapy on Reproductive Disorders and Cardiovascular Risks in Overweight Polycystic Ovarian Syndrome (PCOS) PatientsStatus: Completed, Estimated PCD: 2021-04-01
Clinical trial
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor AgonistsStatus: Recruiting, Estimated PCD: 2026-09-30
Product
MirabegronClinical trial
Inositol Supplementation to Treat Polycystic Ovary Syndrome: A Double Blind Dose Ranging RCT (INSUPP-PCOS)Status: Recruiting, Estimated PCD: 2024-08-31
Product
InositolClinical trial
Effect of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary SyndromeStatus: Not yet recruiting, Estimated PCD: 2024-08-01
Product
DaflonProduct
Combined Oral ContraceptiveClinical trial
Treating Polycystic Ovarian Syndrome (PCOS) With Digital Intervention vs. MetforminStatus: Completed, Estimated PCD: 2023-08-12
Clinical trial
Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess (CBS006)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Effect of GnRH Agonist (Long Protocol) vs GnRH Antagonist (Flexible Protocol) on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.Status: Completed, Estimated PCD: 2021-08-15
Clinical trial
Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled TrialStatus: Recruiting, Estimated PCD: 2024-04-30
Drug
Vitamin D3Product
Recombinant-FSHClinical trial
Efficacy of Jianpi Qushi Huatan Decoction in the Treatment of Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled TrialStatus: Recruiting, Estimated PCD: 2025-09-01
Drug
VarlilumabClinical trial
Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome : a Double-blind, Randomized and Placebo-controlled StudyStatus: Recruiting, Estimated PCD: 2025-09-01
Product
Bushen Huatan DecoctionClinical trial
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome: A Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2024-04-01
Product
Metformin HydrochlorideProduct
VildagliptinClinical trial
Metformin Treatment in Adolescent Patients With PCOS: A Long-term, Winning Metabolic Choice. Results From a Single Center 5-years Retrospective Clinical StudyStatus: Completed, Estimated PCD: 2019-08-01
Clinical trial
Is the Co-administration of Metformine and CC as Compared to Placebo and CC Superior to Induce Ovulation in PCOS Patients With a Confirmed insulin-resistant-a Double Blind Randomized Clinical TrialStatus: Terminated, Estimated PCD: 2022-04-01
Product
metformineClinical trial
The Effects of Semaglutide on Modulation of Taste Sensitivity, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Responses in Women With PCOS and Obesity: a Randomized, Single-blind, Placebo-controlled Clinical TrialStatus: Completed, Estimated PCD: 2020-05-08
Clinical trial
Compare Weight Loss and Metabolic Improvements Using a Low Starch Dietary Education Program vs. Traditional Treatment for Polycystic Ovary Syndrome (PCOS)Status: Completed, Estimated PCD: 2022-10-10
Clinical trial
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOSStatus: Completed, Estimated PCD: 2023-03-31
Product
CabergolineClinical trial
Progesterone-Primed Ovarian Stimulation Might be a Safe and Effective Alternative to GnRH-antagonist Protocol for Controlled-Ovarian Stimulation of Infertile PCOS WomenStatus: Completed, Estimated PCD: 2022-09-14
Product
DydrogesteroneClinical trial
Administration of Kisspeptin to Subjects With Reproductive DisordersStatus: Recruiting, Estimated PCD: 2025-08-01
Product
Metformin + CabergolineClinical trial
The Effect of Semaglutide Compared to Metformin in Obese Women With Polycystic Ovary Syndrome (PCOS): a Randomised Controlled Study (Semaglutide-PCOS Trial).Status: Not yet recruiting, Estimated PCD: 2025-09-30
Clinical trial
Comparing the Effects of Oral Contraceptive Pills Versus Metformin in the Medical Management of Overweight/Obese Women With Polycystic Ovary SyndromeStatus: Completed, Estimated PCD: 2024-01-23
Product
OCP + MetforminProduct
OCPProduct
Metformin + PlaceboClinical trial
Effects of Myo-inositol on the Menstrual Cycle, Hyperandrogenism, Chronic Inflammatory Process and Carbohydrate Metabolism in Women With Polycystic Ovary SyndromeStatus: Completed, Estimated PCD: 2023-10-20
Product
Myo-inositolClinical trial
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome: a Prospective, Randomized, Open, Controlled StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian DysfunctionStatus: Recruiting, Estimated PCD: 2024-07-31
Product
SalsalateClinical trial
The Effect of Adding L-carnitine During Ovarian Stimulation With Antagonistic Protocol in Patients With Polycystic Ovarian Syndrome on the Outcome of IVF / ICSI Cycle: A Double Blind Randomized Clinical TrialStatus: Completed, Estimated PCD: 2022-12-29
Product
L-carnitineClinical trial
PCOS, Sleep Apnea and Metabolic Risk in WomenStatus: Active (not recruiting), Estimated PCD: 2022-06-30
Product
Depot LupronClinical trial
Effect of Sitagliptin on Clinical, Metabolic and Hormonal Parameters in Polycystic Ovarian Syndrome PatientsStatus: Not yet recruiting, Estimated PCD: 2023-10-30
Product
SitagliptinClinical trial
A Comparison Between Corifollitropin Alfa and Recombinant FSH for Follicular Recruitment in Women With Polycystic Ovaries Who Undergo IVM TreatmentStatus: Completed, Estimated PCD: 2022-12-31
Product
Corifollitropin AlfaProduct
Follitropin betaProduct
MarvelonClinical trial
Comparison of the Clinical Efficacy of Laparoscopic Sleeve Gastrectomy and Metformin in the Treatment of Obese Patients With Polycystic Ovary SyndromeStatus: , Estimated PCD: 2024-09-01
Clinical trial
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian SyndromeStatus: Completed, Estimated PCD: 2009-08-01
Product
Clomiphene citrateProduct
raloxifeneClinical trial
Clinical and Basic Research on the Treatment of Zishen Qingre Lishi Huayu Method on Zin Deficiency and Dampness Type Polycystic Ovary Syndrome: a Multi-center, Double-blind, Randomized and Placebo-controlled StudyStatus: Completed, Estimated PCD: 2021-08-20
Clinical trial
The Effect of Anti Depressive Medicine on Adrenal Activity, Glucose Metabolism, Physical and Mental Health in Polycystic Ovary Syndrome. -A Randomised, Double Blinded, Placebo Controlled Study.Status: Completed, Estimated PCD: 2017-10-01
Product
EscitalopramClinical trial
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment StrategyStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Clinical trial
Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOSStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Sleep, Metabolic, and Cardiovascular Dysfunction in Polycystic Ovary SyndromeStatus: Terminated, Estimated PCD: 2008-06-01
Product
pioglitazoneClinical trial
A Randomized Controlled Study of Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patients in Intracytoplasmic Sperm Injection CyclesStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Product
Progesterone antagonistClinical trial
Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS: an Open-label, Non-randomized Controlled Clinical StudyStatus: Completed, Estimated PCD: 2024-04-01
Product
DingKunDan(GuangYuYuan)Clinical trial
Metabolic Responses of Metformin and Genetic Polymorphisms (rs628031 and rs2282143) of Solute Carrier Family 22 Member 1 Gene in Polycystic Ovary SyndromeStatus: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS WomenStatus: Completed, Estimated PCD: 2023-07-06
Clinical trial
Effect of Myoinositol on Serum Asprosin Levels in PCOS PatientsStatus: Completed, Estimated PCD: 2022-09-30
Product
Inofolic CombiProduct
GlucophageClinical trial
The Evaluation of the Effect of Dihydroartemisinin in Patients With Polycystic Ovary SyndromeStatus: Completed, Estimated PCD: 2023-03-23
Product
DihydroartemisininClinical trial
Therapeutic Efficacy of Dihydroartemisinin in Patients With Polycystic Ovary SyndromeStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Letrozole Dose Increments in PCOS Patients Resistant to Letrozole Ovulation InductionStatus: Completed, Estimated PCD: 2024-01-30
Clinical trial
Dietary Fish Oil and Metformin Intervention for Heart Health in PCOSStatus: Not yet recruiting, Estimated PCD: 2026-06-30
Product
Fish OilClinical trial
A Multicentre, Phase-II, Randomised, Double Blind, Placebo-controlled Study to Assess the Safety and the Efficacy of a Weekly Administered Dose of 30,000 IU Vitamin D (Colecalciferol) in Deficient Patients Diagnosed With PCOSStatus: Completed, Estimated PCD: 2022-02-01
Clinical trial
Association of Serum Biomarkers in Polycystic Ovarian Syndrome (PCOS) Females With and Without Metformin Versus Healthy ControlsStatus: Recruiting, Estimated PCD: 2025-05-30